CK
Chaitali Kalpataru Shah
About Chaitali Kalpataru Shah
Data last updated:
Chaitali Kalpataru Shah is an Additional Director at Bacil Pharma Ltd (since 2025) and Director at Bacil Research & Development Private Limited (since 2026). The companies operate in Pharma. The largest current company by reported revenue is Bacil Pharma Ltd at ₹66.1 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Additional Director | 16 Jul 2025 | 1987 | ₹66.1 Lakh (FY 2025) | Active | |
| Director | 28 Jul 2026 | 2026 | Active |
Board colleagues of Chaitali Kalpataru Shah
| Name | DIN | Company | Designation |
|---|---|---|---|
| Dikshant Singh Panwar | Bacil Pharma Ltd | Company Secretary | |
| Omprakash Pyarelal Sonar | 11031877 | Bacil Pharma Ltd | Additional Director |
| Vivek Mukesh Yadav | 11033957 | Bacil Pharma Ltd , Bacil Research & Development Private Limited | Additional Director |
| Anil Shiv Charan Singh | 09338444 | Bacil Research & Development Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Chaitali Kalpataru Shah
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Chaitali Kalpataru Shah
Chaitali Kalpataru Shah currently holds 2 directorships: Bacil Pharma Ltd (Additional Director, since 16 Jul 2025, revenue ₹66.1 Lakh (FY 2025)); Bacil Research & Development Private Limited (Director, since 28 Jul 2026).
Chaitali Kalpataru Shah was first appointed on 16 Jul 2025 as Additional Director at Bacil Pharma Ltd. The most recent appointment on record is 28 Jul 2026 at Bacil Research & Development Private Limited.
The current boards of Chaitali Kalpataru Shah's companies include Dikshant Singh Panwar (Bacil Pharma Ltd), Omprakash Pyarelal Sonar (Bacil Pharma Ltd), Vivek Mukesh Yadav (Bacil Pharma Ltd), Anil Shiv Charan Singh (Bacil Research & Development Private Limited).